IN8bio Inc (INAB)
1.03
-0.10
(-8.85%)
USD |
NASDAQ |
May 16, 16:00
1.03
0.00 (0.00%)
After-Hours: 20:00
IN8bio Shareholders Equity (Quarterly): 17.53M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 17.53M |
December 31, 2023 | 24.94M |
September 30, 2023 | 17.76M |
June 30, 2023 | 21.80M |
March 31, 2023 | 16.79M |
December 31, 2022 | 22.73M |
September 30, 2022 | 29.56M |
June 30, 2022 | 26.57M |
Date | Value |
---|---|
March 31, 2022 | 32.84M |
December 31, 2021 | 38.18M |
September 30, 2021 | 43.04M |
June 30, 2021 | 13.66M |
March 31, 2021 | 16.32M |
December 31, 2020 | 18.32M |
June 30, 2020 | 0.835M |
December 31, 2019 | -0.346M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-0.346M
Minimum
Dec 2019
43.04M
Maximum
Sep 2021
21.28M
Average
20.06M
Median
Shareholders Equity (Quarterly) Benchmarks
Jaguar Health Inc | 4.961M |
Aptevo Therapeutics Inc | 6.103M |
NovaBay Pharmaceuticals Inc | 0.16M |
Palatin Technologies Inc | -11.38M |
iBio Inc | 9.197M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 25.55M |
Total Liabilities (Quarterly) | 8.023M |